Cambium Bio Ltd (CMB) - Cash Flow Conversion Efficiency

Latest as of June 2025: -1.444x

Based on the latest financial reports, Cambium Bio Ltd (CMB) has a cash flow conversion efficiency ratio of -1.444x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.65 Million ≈ $-1.88 Million USD) by net assets (AU$1.84 Million ≈ $1.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CMB stock market capitalisation for the company's overall valuation and market capitalisation.

Cambium Bio Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Cambium Bio Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cambium Bio Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cambium Bio Ltd ranked by their cash flow conversion efficiency. Explore CMB operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Avrasya Petrol ve Turistik Tesisler Yatirimlar AS IS:AVTUR	0.010x
KB SPAC 6 KQ:208640	-0.015x
elumeo SE XETRA:ELB	0.087x
Companhia de Fiacao e Tecidos Cedro Cachoeira SA:CEDO3	0.099x
Eifelhöhen-Klinik AG F:EIF	-0.003x
Trencor JSE:TRE	0.000x
Logismos Information Systems S.A AT:LOGISMOS	0.026x
BioRestorative Therapies Inc NASDAQ:BRTX	-1.259x

Annual Cash Flow Conversion Efficiency for Cambium Bio Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Cambium Bio Ltd from 1999 to 2025. View CMB stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.84 Million ≈ $1.30 Million	AU$-5.24 Million ≈ $-3.71 Million	-2.856x	-4986.40%
2024-06-30	AU$2.78 Million ≈ $1.96 Million	AU$-155.86K ≈ $-110.28K	-0.056x	-116.58%
2023-06-30	AU$-1.95 Million ≈ $-1.38 Million	AU$-660.46K ≈ $-467.32K	0.339x	+110.13%
2022-06-30	AU$1.07 Million ≈ $760.48K	AU$-3.59 Million ≈ $-2.54 Million	-3.341x	-672.70%
2021-06-30	AU$4.15 Million ≈ $2.93 Million	AU$2.42 Million ≈ $1.71 Million	0.583x	+132.85%
2020-06-30	AU$1.09 Million ≈ $774.10K	AU$-1.94 Million ≈ $-1.37 Million	-1.776x	-414.34%
2019-06-30	AU$-6.39 Million ≈ $-4.52 Million	AU$-3.61 Million ≈ $-2.55 Million	0.565x	+138.87%
2018-06-30	AU$2.92 Million ≈ $2.07 Million	AU$-4.25 Million ≈ $-3.01 Million	-1.454x	-428.22%
2017-06-30	AU$8.10 Million ≈ $5.73 Million	AU$3.59 Million ≈ $2.54 Million	0.443x	+194.04%
2016-06-30	AU$4.78 Million ≈ $3.39 Million	AU$-2.25 Million ≈ $-1.59 Million	-0.471x	+34.23%
2015-06-30	AU$8.27 Million ≈ $5.85 Million	AU$-5.92 Million ≈ $-4.19 Million	-0.716x	+4.65%
2014-06-30	AU$8.31 Million ≈ $5.88 Million	AU$-6.24 Million ≈ $-4.41 Million	-0.751x	-146.66%
2013-06-30	AU$-2.87 Million ≈ $-2.03 Million	AU$-4.62 Million ≈ $-3.27 Million	1.610x	+206.69%
2012-06-30	AU$1.95 Million ≈ $1.38 Million	AU$-2.94 Million ≈ $-2.08 Million	-1.509x	-372.04%
2011-06-30	AU$3.29 Million ≈ $2.33 Million	AU$-1.05 Million ≈ $-743.44K	-0.320x	-338.79%
2002-06-30	AU$40.54 Million ≈ $28.68 Million	AU$5.43 Million ≈ $3.84 Million	0.134x	-31.25%
2001-06-30	AU$196.21 Million ≈ $138.83 Million	AU$38.20 Million ≈ $27.03 Million	0.195x	-35.02%
2000-06-30	AU$161.09 Million ≈ $113.98 Million	AU$48.26 Million ≈ $34.15 Million	0.300x	+17.02%
1999-06-30	AU$130.56 Million ≈ $92.38 Million	AU$33.43 Million ≈ $23.65 Million	0.256x	--

About Cambium Bio Ltd

AU:CMB Australia Biotechnology

Market Cap

$10.06 Million

AU$14.21 Million AUD

Market Cap Rank

#27166 Global

#1298 in Australia

Share Price

AU$0.52

Change (1 day)

+4.00%

52-Week Range

AU$0.35 - AU$0.60

All Time High

AU$22.97